Pliant Therapeutics, Inc.
PLRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746473
No open-market purchases or sales by Pliant Therapeutics, Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $54.8M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Pliant Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 136 | 1 | 134 | −1 |
| Shares | 60.2M | 3.01M | 62.7M | +5.57M (+9.7%) |
| Value | $1.04B | $52.3M | $1.14B | +$144.9M (+14.6%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Pliant Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Blue Owl Capital Holdings LP | 3,004,199 | $54.4M | 13.01% |
| Rhenman & Partners Asset Management AB | 112,741 | $2.04M | 0.20% |
| Exome Asset Management LLC | 49,580 | $897.9K | 0.89% |
| Hudson Bay Capital Management LP | 45,000 | $815.0K | 0.01% |
| Balyasny Asset Management LLC | 37,143 | $672.7K | 0.00% |
| American Century Companies Inc | 30,895 | $559.5K | 0.00% |
| HRT Financial LP | 28,430 | $514.0K | 0.00% |
| HighMark Wealth Management LLC | 23,500 | $425.6K | 0.31% |
| Prelude Capital Management, LLC | 21,509 | $389.5K | 0.03% |
| Algert Global LLC | 16,930 | $306.6K | 0.01% |
| Landscape Capital Management, L.L.C. | 16,146 | $292.4K | 0.03% |
| EntryPoint Capital, LLC | 10,014 | $181.4K | 0.17% |
| West Tower Group, LLC | 4,701 | $85.1K | 0.17% |
| Quest Partners LLC | 2,051 | $37.1K | 0.01% |
| Allworth Financial LP | 157 | $2.84K | 0.00% |
| Salem Investment Counselors Inc | 60 | $1.09K | 0.00% |
| EverSource Wealth Advisors, LLC | 59 | $1.07K | 0.00% |
| GAMMA Investing LLC | 20 | $358 | 0.00% |
| Farther Finance Advisors, LLC | 6 | $109 | 0.00% |
Sold out (20)
Institutions that held Pliant Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| First Manhattan Co | 370,200 | $6.42M |
| VR Adviser, LLC | 288,949 | $5.01M |
| Millennium Management LLC | 181,884 | $3.15M |
| Polar Asset Management Partners Inc. | 124,000 | $2.15M |
| Two Sigma Investments, LP | 102,709 | $1.78M |
| Jump Financial, LLC | 78,768 | $1.37M |
| Marshall Wace, LLP | 73,921 | $1.28M |
| Voloridge Investment Management, LLC | 62,941 | $1.09M |
| D. E. Shaw & Co., Inc. | 48,999 | $849.6K |
| Gsa Capital Partners LLP | 45,587 | $790.0K |
| Trexquant Investment LP | 42,277 | $733.1K |
| Quantbot Technologies LP | 32,735 | $567.6K |
| Capstone Investment Advisors, LLC | 22,711 | $393.8K |
| Profund Advisors LLC | 12,405 | $215.1K |
| Bayesian Capital Management, LP | 12,000 | $208.1K |
| XTX Topco Ltd | 11,963 | $207.4K |
| Geneos Wealth Management Inc. | 3,100 | $53.8K |
| Artal Group S.A. | 1,490 | $26.0K |
| Quadrant Capital Group LLC | 162 | $2.81K |
| CWM, LLC | 7 | $0 |
Not filed for Q4 2023 yet (1)
Institutions that held Pliant Therapeutics, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| CHI Advisors LLC | 3,014,199 | $52.3M |